To cite this paper use one of the standards below:
INTRODUCTION AND OBJECTIVES: XIAP (X-linked inhibitor of apoptosis protein) is an apoptosis inhibitor protein with a canonical function of direct inhibition of caspases. It is found mostly in the cytoplasm, but its presence in the nucleus has been associated with drug resistance and poor prognosis in a subgroup of breast cancer patients. It is also known that classical nuclear-cytoplasmic transport is often modified in cancer, which could result in altered subcellular localization of the protein. As breast cancer has a high incidence and mortality and nucleocytoplasmic shuttling is deregulated in tumours, it is important to study XIAP nuclear localization. In this context, the aim of the study is to investigate whether importin inhibition can modulate XIAP nuclear localization and drug responses in chemoresistant tumour models. MATERIAL AND METHODS: The transcript and protein levels of α5, α2 and β1 importins were evaluated by real time PCR and Western Blotting in breast cancer cell lines and in doxorubicin-resistant OvCar DoxR cell line (endogenous nuclear XIAP) as well as in breast cancer samples patients from TCGA public datasets deposited in the UALCAN platform. MTT and clonogenic assays with nuclear import inhibitors of α/β1 importins, ivermectin and INI-43, were performed. Furthermore, we evaluated XIAP subcellular localization with ivermectin and INI-43 treatments in OvCar DoxR cell line and MCF-7 cell line transiently transfected with XIAPwild type (cytoplasmic XIAP localization) and XIAPNLS (nuclear XIAP localization) by Western Blotting and immunofluorescence. Finally, we analysed the synergistic effect of the combination of treatment with INI-43 and doxorubicin and docetaxel chemotherapeutics. RESULTS AND CONCLUSION: We observed that gene and protein expression of the α5, α2 and β1 importins was upregulated in breast tumours compared to normal tissues. Differential protein levels were also found in cell lines exhibiting distinct drug resistance phenotypes. MCF-7 and MDA-MB-231 cell lines were sensitive not only to the chemotherapeutics doxorubicin and docetaxel, but also to importin inhibitors. Interestingly, the drug resistant OvCar DoxR cell line exhibited pronounced sensitivity to importin inhibitors. We also found that Ivermectin and INI-43 promoted XIAP nuclear exclusion in exogenous and endogenous nuclear XIAP expression models. Moreover, the combination of doxorubicin or docetaxel showed a synergistic effect with INI-43 in drug resistant cells. These results indicate that the inhibition of importins can interfere with XIAP nuclear localization and sensitize resistant cancer cells to chemotherapy in our tumour models, with a great potential for intervention in chemoresistant tumors.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper